ADDF STATEMENT ON LECANEMAB DATA PRESENTED AT CTAD ...Middle East

PR Newswire - News
ADDF STATEMENT ON LECANEMAB DATA PRESENTED AT CTAD
Positive results from new amyloid-clearing drug represent starting point for Alzheimer's treatment, while combination therapy remains holy grail SAN FRANCISCO, Nov. 29, 2022 /PRNewswire/ -- Based on study results presented today at the 15th Clinical Trials on Alzheimer's Disease (CTAD)...

Read More Details
Finally We wish PressBee provided you with enough information of ( ADDF STATEMENT ON LECANEMAB DATA PRESENTED AT CTAD )

Also on site :